Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan · Delayed Price · Currency is JPY 3,885.00
+55.00 (1.44%)
Sep 14, 2026, 3:30 PM JST
Kaken Pharmaceutical Market Cap
Kaken Pharmaceutical has a market cap or net worth of 147.12 billion as of September 14, 2026. Its market cap has decreased by -0.35% in one year.
Market Cap
147.12B
Enterprise Value
92.82B
Revenue
88.16B
Ranking
n/a
PE Ratio
14.27
Stock Price
3,885.00
ChartMarket Cap Chart
Since March 26, 1993, Kaken Pharmaceutical's market cap has increased from 118.38B to 147.12B, an increase of 24.28%. That is a compound annual growth rate of 0.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 147.12B | -3.24% |
| Dec 30, 2025 | 152.04B | -11.05% |
| Dec 30, 2024 | 170.93B | 34.53% |
| Dec 29, 2023 | 127.05B | -12.84% |
| Dec 30, 2022 | 145.77B | -8.45% |
| Dec 30, 2021 | 159.22B | 3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tsumura & Co. | 277.09B |
| Nippon Shinyaku | 228.22B |
| Sawai Group Holdings | 182.53B |
| Towa Pharmaceutical | 173.28B |
| Kissei Pharmaceutical | 165.39B |
| Mochida Pharmaceutical | 111.43B |
| Zeria Pharmaceutical | 87.37B |
| KYORIN Pharmaceutical | 62.67B |